6505-01-016-1406 ( NDC00003-1194-50 , VELOSEF 250 )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-01-016-1406 | 6505 | 010161406 | CEPHRADINE FOR ORAL SUSPENSION,U | 3595 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| AGXW | PHYSICAL FORM | POWDER |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 MILLILITERS AFTER RECONSTITUTION |
| SUPP | SUPPLEMENTARY FEATURES | MEDSEP ITEM FOR DOD,SQUIBB |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 250.000 MILLIGRAMS CEPHRADINE PER 5 MILLILITERS OF RECONSTITUTED SUSPENSION |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| NDC00003-1194-50 | 78473 | F | 2 | 3 | 6 | 54 | |
| VELOSEF 250 | 78473 | F | 1 | 3 | 4 | 75 |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| NDC00003-1194-50 | 78473 | SQUIBB E R AND SONS INC | A | F |
| VELOSEF 250 | 78473 | SQUIBB E R AND SONS INC | A | F |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| A | X | A | 1 | 02/04/1 | P | 3004909185 | 3595 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|---|---|---|---|---|
| VA | V | K | U/I CONTAINS 100 ML | ||
| DN | 9L----- | N | V | DISCONTINUED W/O REPLACEMENT |
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|---|---|---|---|---|
| A | A | P | X |
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|---|---|---|---|---|---|---|---|---|
| DN | S9M | Y | 1 | BT | M | U | 9L----- | N | |
| VA | I | 0 | BT | M | U | V |
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|